- Report
- October 2024
- 120 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 250 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- January 2025
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
- Book
- August 2019
- 416 Pages
Cholinesterase is an enzyme that plays an important role in the nervous system. It is responsible for breaking down the neurotransmitter acetylcholine, which is involved in muscle contraction, memory, and learning. Cholinesterase inhibitors are used to treat a variety of neurological disorders, including Alzheimer's disease, myasthenia gravis, and glaucoma.
The cholinesterase market is a rapidly growing segment of the enzyme industry. It is driven by the increasing prevalence of neurological disorders, as well as the development of new treatments. Companies in the market are focused on developing and manufacturing cholinesterase inhibitors, as well as providing services related to their use.
Some of the major companies in the cholinesterase market include Merck, Pfizer, Novartis, and GlaxoSmithKline. Other companies include AbbVie, AstraZeneca, and Johnson & Johnson. Show Less Read more